Answered You can buy a ready-made answer or pick a professional tutor to order an original one.
Click here to find four research studies in different topic areas in the National Institute of Mental Health (NIMH) website. For example, you might look at the studies being conducted on panic disorde
Click here to find four research studies in different topic areas in the National Institute of Mental Health (NIMH) website. For example, you might look at the studies being conducted on panic disorder and depression. Read about each study and create a table to organize the required summary information.
For each study, you must state:
- Study title
- Purpose of the study
- Study type
- Study design
- Three primary outcome measures
- Estimated enrollment number
- Brief description about the study
- Eligibility requirements
- One inclusion criterion and one exclusion criterion
- Study location
- One principal investigator
After finding the required information, write a brief report on what you learned about the various types of studies being conducted at NIMH. Submit the report in a 3- to 4-page Microsoft Word document along with the information on the four studies.
- @
- 959 orders completed
- ANSWER
-
Tutor has posted answer for $30.00. See answer's preview
******* ********* ** **** * ***** ************* * Development of ********** *** ********** ******** Resonance Imaging ********** for *** ***** ** **** and ******* DisordersPurpose * *** ***** ** ******** ** assist ** ********** *** ******** resonance imaging ***** imaging ******* ** studying ******* and **** ********* Researchers *** **** **** ********** *** ******* ********* *** ****** ** ********** *** ********** ******* in *** ***** *** ***** **** ***** *** way ** MRI ***** *** ********* ** **** ** ***** *********** *** ********* *** *** ***** behaves **** ******** ******* specific ***** ******* usual ********** at *** *** ** ** *** ***** *** have ***** suffered **** *** *********** ******** *** *** **** ** *********** ********* with **** ********* *** ** appropriate *** this ********* * ObservationalDesign - Time ******************* ******** – *** ******* ** **** ************* **** ** *** ********** to get functional *** ********** images ** the brain **** **** ******* ************* *** ******** 750-1000 micron and 100-300 ****** *** respectively *** ******** benefits of blood **** ** well ** *** **** ********** *** methods and ***** ******** ****** ******** **** ** ********** Also ** ******* the ability ** *** ******** ************* **** at 5mm ******** The last ******* **** be the ******* ** gain ************* EEG **** ************ with the ********** *** ************** ****** - ************** * *** ******* ********* ** ********* the pathogenesis of mood *** ******* ******** ** ********* ** ******* *********** ** ******* ** ***** ********* as **** ** a ******** ******* ** ***** conditions *********** ************* and ***************** *********** involved *** ******* methods *** inspecting ************* of brain ********* ******** **** *** ******* ** *********** ********* On the ***** hand the ********** ** *** ******** **** **** ******* *** **** ********* ** *** ************* **** ************ ** ********* **** candidates **** anxiety *** mood ********* *** *** **** unmediated *** ********** ************* ********************* * The age ******** *** *** ***** ** between ** ** ** years (Adults) and all sexes *** ********* *** ****** ******* volunteersInclusion ********* - Healthy ********* Both **** and ****** candidates **** ******* ** *** ** ************** ********* * ******* ********* ******** with primary ************ ********* ********* to signify ******** ***** **** that ** likely ** ****** *** ******* *********** of awareness ****** ***** ***** of scanningLocation * ****** States ******************** * ****** Nugent *** National Institute ** ****** ****** ******* ************* ***** - A *************** ************* of Patients **** ************* Spectrum Disorders *** Their *************** - **** ** * *********** ******* study ** NIMH **** ************ *** neurobiology ** ************* ******* finding ************** ***** ********** ***** ******* ** ***** ******** to ****** ********** *** ** control *** ******* **** illnessType - ObservationalDesign ************ * relationship ****** ****** than linkage ******** will ******* measurable *************** ********* which **** been ***** there before ** ******** ********** associated **** ************* ** ******** tests ** ********* *** cognitionOutcome ******** * ** **** use ******** *********** techniques ** **** that individual ******* ************* ****** ***** ********** ********* Genetic ******* ************ Coefficient and *** of *** **** ** ***************** number * 6150Description * ************* is * ******** ******* ******** **** is likely to ******* ******** genes **** ************ * slight improvement ** risk ********* *********** ***** ** **** ******* ******** *** **** ******* and **** ****** need **** proposals *** ***** ******** specimens ********* ********** **** ******** risen that seem ** considerably advance *** potential ** ******* studies *** identifying **** genes ** ******** ***** connections *** ******* ** well as ***** standard phenotypes ** ******** ** ****** diagnosisEligibility - **** Eligible *** ***** are **** 18 ***** and ****** ******** *** ***** are *** ****** and *** study ******* healthy ******************* criterion * ********* ******** *** Siblings: the ********** and ********* siblings Pro-bands ****** **** * *** **** *********** ** ************* **************** disorder psychosis *** ** *************** ***************** ********* - Breakdown ******** ******* brain damage ****** *********** or ******* ************ diseaseLocation * ****** ****** ******************** - ***** * Berman MD ******** Institute ** ****** ****** ******* DepressionTitle:Neurobiological ** ******* ******* - ***** *** no ****** ********** *** ****** ********** ******* *********** want ** study ***** with ********* ***** ***** ***** ******* *** ***** ******* **** **** to ********** ******* better so they can **** ******** ********** - ************** ****** * ************** ************ ******** * ******** ****** ********** ***** ************* ***** ****************** *********** ****** ***** *** Anxiety ************* hours ********** ***************** ********** ********** ******* ************* hours ******************** ****** * **************** - Suicide occurs ****** psychiatric ********* *** *********** executing ** ***** *** million people ** *** ***** ***** ***** **** In ************* ** ***** injury-related ***** **** as ****** or car ********* ******* ***** **** ****** specifically among ********* and ******* ***** of 170 individuals *** ******** in *** ***** Membership societies *** ****** **** *** ********* *************** Current **************** ideation **** ****** *** suicide ******* ****** ** active ****** ** ***** * previous ******* ** ******* ***** *** no miserable ******** ** the last year ****** * n= ***** **** ** anxiety *********** *** ** current or **** ******** ******** ** behavior ****** * ** ***** ******* ******** **** no *********** ** suicide ******* (Group * n= 40)Eligibility * *** ** from18 ***** to 70 ***** andGender eligible *** Study *** all ****** *** *** ***** ******* ******* volunteersInclusion ********* * *** ***** ** ******* ****** ** agree ** *** ****** ***** *** *********** symptoms an ******** ******** ******** and confirm ************* by a score greater **** ** equal ** 90% ** *** ******** ******* ***************** ********* * ******* psychopathic features ** ********* ********** that would ******* ************* of *** consenting manner ** ************************** - ****** ****** MarylandInvestingator * ****** * Zarate ** ******** ********* ** ****** ****** ******* ******* ********* ***** * ******* and ********* Abdominal Pain ** *************** * **** ***** is ******** ** ********* ** citalopram ** a ************** ****** *** **** ********* *** **** *** adolescents ******* *** *** * *** ** ***** with ********* ********** ******** * ******************** * *********** RandomizedOutcome Measures * ************ ********* ********** ***** - ********** (CGI-I) **** ** used ** ****** complete worldwide ******* *********** ***** ****** ** 1 ****** much ********** ** * ****** improved") show an ******** ********* ******** ***** Frame: The *** **** ** **** ** ***** * * and 8)Enrollment number * ************** * *** ***** intends ** discover *** ******** efficiency safety *** ************ of *** citalopram in *** therapy of ********* operative ******* ********** **** ** children *** ********* **** * *** 18 ***** *** **** *** ********* is ** ******* and ********* *** ******** to ********** ** ****************** ************ ***** Eligible for ****** * Years ** ******* (Child Adult)Sexes ******** *** Study: ********** ******* Volunteers: *********** Criterion * ** least ***** occurrences of abdominal **** ********** the previous ***** ****** linked **** ********* ********** ** *** ********** of critical physical ******* ********* ********** *********** medical ******************* ********* - Physical ******* is ****** ** explain the ****** ******** *** ********** ********** ******** ** *** subjectLocation * ****** ****** **************** * **** V Campo ** *** ******** ********* ** ********** ********** Hospital References **** J ****** The ************ ** ************* ************ *********** * ***** * J Barbero G ***** ******** * (1985) ******* ** ******** with ********* ********* **** *** ***** *************************** ************** WC ***** ** ******* ** Jr Todd ** ***** * ******* * ******* ** ********* ********** cortex ************* ** **** ********* ****** **** Apr *************************** C * (1987) Genetic principles *** ******* ** ********* ******* ** ************************** ************* *********
